Physician

Tony Tsai, M.D.

According to 2025 Medicare claims, Tony Tsai, M.D. (NPI: 1548294101) practices ophthalmology in the Chico, CA market, with the plurality of this provider's patient population coming from Butte, CA. This provider's primary affiliated billing organization is VITREO-RETINAL MEDICAL GROUP, INC. (NPI: 1184717167; TIN: 942442567) and primary practice location at 95928-9224. Tsai is affiliated with the NeueHealth Premier ACO, LLC (ACO ID: D0181) and NeueHealth Community ACO, LLC (ACO ID: D0324), participating under the REACH model.

Tsai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,494 traditional Medicare patients, billed 60,168 HCPCS/CPT codes, and received $3,855,882 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 566 prescription claims across 234 beneficiaries totaling $18,461 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). 2015 DME data shows 19 claims. Open Payments data shows 14 records totaling $798. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $44,600 to $18,461. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,386	24,595	$4,266,933
2016	2,011	22,945	$3,860,858
2017	1,602	20,531	$3,544,051
2018	1,775	19,857	$3,044,672
2019	1,685	19,309	$2,843,737
2020	1,730	19,668	$3,399,891
2021	1,760	19,212	$3,634,443
2022	1,692	24,773	$4,031,859
2023	1,612	53,422	$3,977,390
2024	1,494	60,168	$3,855,882

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	271	790	$44,600
2016	292	738	$45,873
2017	244	670	$35,907
2018	262	688	$45,279
2019	217	512	$38,568
2020	245	657	$44,214
2021	258	726	$56,932
2022	240	588	$42,055
2023	223	534	$24,587
2024	234	566	$18,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	19	$1,330
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	262	282	$145
67028	Injection of drug into eye	510	1,774	$105
92014	Established patient complete exam of visual system	803	1,052	$95
92012	Established patient problem focused exam of visual system	271	437	$76
92134	Imaging of retina	1,290	3,056	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	145	5,160	$7,292
Ketorolac Tromethamine	Ketorolac Tromethamine	57	2,174	$1,290
Ofloxacin	Ofloxacin	104	1,942	$1,049
Brimonidine Tartrate	Brimonidine Tartrate	35	2,224	$1,002
Timolol Maleate	Timolol Maleate	43	3,008	$659

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$798	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tony Tsai, M.D.?

Tedicare shows public-source Medicare data for Tony Tsai, M.D. (NPI 1548294101), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tony Tsai, M.D. have ACO affiliation data?

Tony Tsai, M.D. is shown with ACO affiliation data for NeueHealth Premier ACO, LLC (REACH, ACO ID D0181) and NeueHealth Community ACO, LLC (REACH, ACO ID D0324).

What billing organization is linked to Tony Tsai, M.D.?

Tony Tsai, M.D. is linked to VITREO-RETINAL MEDICAL GROUP, INC. (billing NPI 1184717167) in the available physician profile data.

Does Tony Tsai, M.D. have Open Payments data?

Tony Tsai, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.